Results 161 to 170 of about 3,598 (226)

Platelet‐Rich Fibrins as Local Drug‐Delivery Carriers

Journal of Periodontal Research, EarlyView.
Autologous platelet concentrates (APCs), particularly platelet‐rich fibrin (PRF), act as biologically active fibrin scaffolds, capable of entrapping and gradually releasing therapeutic agents in oral and periodontal therapy. The incorporation of bioactive compounds, such as antibiotics, antifungals, vitamins, antidiabetic drugs, and exosomes, enhances ...
Karim M. Fawzy El‐Sayed, Christof E. Dörfer   +1 more
wiley   +1 more source

A Novel Approach to Combating Antibiotic Resistance: A Chitosan-Based Nanocomposite with Green AgNPs and Gentamicin. [PDF]

Int J Mol Sci
Madhusudanan M, Singh P, Ghai V, Pandit S, Kádár R, Mijakovic I.   +5 more
europepmc   +1 more source

Optimization of corneal preservation media with novel antifungal agents. [PDF]

Arch Microbiol
Reginatto P, de Jesus Agostinetto G, Locatelli CI, Guareze FS, Joaquim AR, Krummenauer ME, do Nascimento Fuentefria R, Vainstein MH, Marinho DR, de Andrade SF, Fuentefria AM.   +10 more
europepmc   +1 more source

Comparison of ciprofloxacin and aminoglycoside susceptibility testing for ceftriaxone non-susceptible Enterobacterales by disk diffusion and VITEK 2 vs. broth microdilution using updated Clinical and Laboratory Standards Institute breakpoints. [PDF]

BMC Microbiol
Sohani ZN, Lieu A, Semret M, Cheng MP, Simic N, Bamba R, Patel M, Lawandi A, Lee TC.   +8 more
europepmc   +1 more source

Plasmid-linked virulence genes and high-level gentamicin resistance in <i>Enterococcus faecalis</i> from persistent endodontic infections. [PDF]

J Conserv Dent Endod
Castillo-Guevara A, Rodriguez-Ciodaro A, la Espriella CM, Gomez-Cárdenas OE, de León-Frías NE, Díez-Ortega H.   +5 more
europepmc   +1 more source

Innovative Management of Brodie's Abscess: Continuous Local Antibiotic Perfusion in a 14-Year-Old Patient. [PDF]

Am J Case Rep
Sawauchi K, Oe K, Fukui T, Kumabe Y, Muratsu H, Kuroda R, Maruo A.   +6 more
europepmc   +1 more source

In vitro activity of meropenem-vaborbactam combinations and eravacycline against carbapenem-resistant Acinetobacter baumannii. [PDF]

Sci Rep
El-Ashry AH, Abdrabou AM, El-Tantawy N, Mahmoud R, El-Mahdy R.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Gentamicins

Zentralblatt Fur Bakteriologie, Parasitenkunde, Infektionskrankheiten Und Hygiene Zweite Naturwissenschaftliche Abt: Allgemeine, Landwirtschaftliche Und Technische Mikrobiologie, 1977
Gentamicin is a new broad-spectrum antibiotic, basic and water-soluble, produced and developed by Schering Corporation-Bloomfield, New Jersey (1967 and 1968). It is produced by Micromonospora purpurea, a member of a genus of microorganisms from which no other antibiotics have been derived.
A A, Abou-Zeid, Y M, Shehata
exaly   +3 more sources

Synthesis of Gentamicin Minor Components: Gentamicin C1a and Gentamicin C2b

Organic Letters, 2022
Gentamicin C1a and the minor isomer C2b have been reported to have favorable properties in terms of antibacterial activity and toxicity compared to the commercial mixture from which they have previously been isolated by preparative high-performance liquid chromatography.
Santanu Jana, David Crich
openaire   +2 more sources

Gentamicin Vestibulotoxicity

Otolaryngology–Head and Neck Surgery, 1994
We reviewed 36 patients with gentamicin vestibulotoxicity to determine its relationship to gentamicin dosage, serum gentamicin levels, and the development of gentamicin nephrotoxicity. Thirty of the patients had received intravenous or intramuscular gentamicin; six had received intraperitoneal gentamicin.
G M, Halmagyi, C M, Fattore, I S, Curthoys, S, Wade   +3 more
openaire   +2 more sources